Differing validity of non-invasive thoracic bioimpedance based determination of cardiac index in patients with and without systolic heart failure

• Conditions: I50; Heart failure

• Registration Number: DRKS00018964
• Lead Sponsor: Institut für Schlafmedizin und neuromuskuläre Erkrankungen, Universtitätsklinikum Münster

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-09-05
• Study Start: 2020-03-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Medically indicated right-heart catheterization with determination of cardiac output/stroke volume.

Exclusion Criteria

/

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Coherence of the bioimpedance-measured cardiac output and stroke volume values with the thermodilution measured values;<br>within 3 days after the clinically indicated thermodilution measurement the bioimpedance-based measurement will be done.

Secondary Outcome Measures

Name	Time	Method
Coherence of the primary outcome in patient with and without systolic heart failure